We are live on ! Find out more
HEC

Hudson Executive Capital Portfolio holdings

AUM $151M
1-Year Est. Return 60.14%
This Fund
S&P 500
This Quarter Est. Return
+3.17%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$267M
AUM Growth
-$167M
Cap. Flow
-$179M
Cap. Flow %
-67.11%
Top 10 Hldgs %
100%
Holding
13
New
1
Increased
2
Reduced
3
Closed
4

Top Buys

Rank Stock Value
1
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$22M
2
CIT
CIT Group Inc.
CIT
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 29.14%
2 Financials 23.98%
3 Consumer Staples 13.83%
4 Technology 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$787B
$41.9M 15.72%
200,000
-475,000
-70% -$98.6M
THC icon
2
Tenet Healthcare
THC
$16.9B
$40.8M 15.31%
1,476,411
CIT
3
DELISTED
CIT Group Inc.
CIT
$39.3M 14.75%
1,231,857
+32,000
+3% +$1.04M
EGRX
4
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$36.9M 13.83%
950,600
+528,600
+125% +$22M
WWAV
5
DELISTED
The WhiteWave Foods Company
WWAV
$36.9M 13.83%
785,334
CCMP
6
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$24.8M 9.3%
585,300
CMA
7
DELISTED
Comerica
CMA
$24.6M 9.23%
598,500
-830,500
-58% -$35.4M
CCMP
8
CALL
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$11.9M 4.45%
+280,000
New +$11.7M
CIT
9
CALL
DELISTED
CIT Group Inc.
CIT
$9.57M 3.59%
300,000
-512,500
-63% -$16.7M
KRE icon
10
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.87B
-294,100
Closed -$11.1M
EGRX
11
CALL
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-492,000
Closed -$19.9M
EGRX
12
PUT
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-120,000
Closed -$4.86M
HTWR
13
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
-866,258
Closed -$27.2M

Similar funds

Hudson Executive Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Hudson Executive Capital held 13 positions worth $267M, down 39% from $434M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Hudson Executive Capital withdrew a net $179M in Q2 2016, closing 4 positions and reducing 3 holdings. Its most notable exit was HEARTWARE INTERNATIONAL INC COM STK (DE), an estimated $27.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 14% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Hudson Executive Capital added an estimated $22M to Eagle Pharmaceuticals, Inc..

  • Hudson Executive Capital added most to Eagle Pharmaceuticals, Inc. in Q2 2016, an estimated $22M increase.
  • Hudson Executive Capital's biggest Q2 2016 reduction was Comerica, cutting an estimated $35.4M.
  • Hudson Executive Capital fully exited HEARTWARE INTERNATIONAL INC COM STK (DE) in Q2 2016, selling an estimated $27.2M.
  • Hudson Executive Capital's ten largest holdings make up 100% of its $267M portfolio in Q2 2016.
  • Hudson Executive Capital opened 1 new position and closed 4 in Q2 2016.
  • Hudson Executive Capital's portfolio value fell 39% quarter-over-quarter to $267M.

Based on Hudson Executive Capital's 13F filing for Q2 2016, filed 15 Aug 2016.